STANNOUS MAA KIT
CALGARY RADIOPHARMACEUTICAL CENTRE / ALBERTA HEALTH SERVICES
View this drug's full profile page →
This is a national manufacturer shortage report. It does not confirm whether the product is unavailable at your local pharmacy — call ahead or ask your pharmacist.
Quick answers
Is there a shortage of STANNOUS MAA KIT in Canada?
Yes. STANNOUS MAA KIT 2.1MG has an active shortage reported to Health Canada (last updated September 3, 2026).
Why is STANNOUS MAA KIT not available?
The reason the manufacturer reported: Shortage of an inactive ingredient or component.
When will STANNOUS MAA KIT be available again?
The manufacturer's estimated resolution date is November 30, 2026. This is an estimate and can change; follow this page to get an email when the status changes.
Other Products Containing the Same Active Ingredient
These are other Health Canada-approved human drug products containing the same active ingredient, not currently reported in shortage. Strength, dosage form, and route can still differ — ask your pharmacist whether any of these are appropriate for you. This isn't a guarantee of current stock.
Other Products
PLASBUMIN-5
GRIFOLS THERAPEUTICS LLC
ALBUMIN (HUMAN) 5% SOLUTION, USP
GRIFOLS THERAPEUTICS LLC
ALBUMIN (HUMAN) 25% SOLUTION USP
GRIFOLS THERAPEUTICS LLC
ALBUREX - 25
CSL BEHRING CANADA INC
ALBUREX - 5
CSL BEHRING CANADA INC
STERILE DILUENT FOR ALLERGENIC EXTRACT - ALBUMIN SALINE WITH PHENOL
ALK-ABELLO INC
What this means
Does this mean my pharmacy is out of stock?
Not necessarily — a national shortage doesn't mean every pharmacy has run out. Some locations may still have stock, especially of a specific strength or pack size.
What should I do?
Health Canada classes this as a Tier 3 shortage, its highest-impact category. If you rely on this medication, talk to your pharmacist or care team now rather than waiting for your supply to run low. This product is usually given in a hospital or clinic, where the pharmacy team manages supply. If you're scheduled to receive it, ask your care team.
Estimated Resolution
2026-11-30
~18 days remaining (estimate)
This is the manufacturer's estimated date, not a guarantee — actual resolution may come earlier or later.
DIN
02360845
Strength
2.1MG
Dosage Form
SUSPENSION KIT
Route
INTRAVENOUS
Active Ingredient
ALBUMIN
Tier
Tier 3 — Critical
Last Updated
2026-09-03
Reason for Shortage
Shortage of an inactive ingredient or component.